AMWL AMERICAN WELL CORP

Amwell® adds Vida to its clinical programs portfolio expanding access to obesity and diabetes care

Amwell® adds Vida to its clinical programs portfolio expanding access to obesity and diabetes care

Vida to offer cardiometabolic solutions including GLP-1s and other anti-obesity medications on the Amwell platform

BOSTON and SAN FRANCISCO, Jan. 15, 2025 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leader in digital care, today announced that , a leader in virtual cardiometabolic care, is now part of the clinical programs portfolio on the Amwell platform.

The program, Amwell Cardiometabolic Care Powered by Vida, will be available to Amwell’s expansive client footprint of health plans and employers. Clients will be able to offer their members access to a suite of cardiometabolic care, including obesity, diabetes prevention and management, and behavioral health support. The program will tailor care based on social factors such as food security, financial barriers, cultural norms, and beliefs. Vida’s services are available on the Amwell platform alongside existing virtual primary care, urgent care, behavioral health and other clinical programs in the Amwell ecosystem.

“We are thrilled to partner with Amwell,” said Joe Murad, CEO of Vida Health. “By leveraging our complementary capabilities, we’re making it easier than ever to provide members with personalized, high-touch care. Together, we’re working to reduce member friction, improve health outcomes at scale, and reduce costs.”

of American adults struggle with obesity, a condition that increases the risk of developing diabetes, heart disease and cancer. Together, obesity and diabetes cost the U.S. healthcare system a year.

Vida clinicians prescribe GLP-1s, other anti-obesity medications and lifestyle interventions like Medical Nutrition Therapy. These services are delivered through a value-based, outcomes-driven model that ensures accountability and measurable results.

“We’re pleased Vida is joining the growing number of third-party programs available through Amwell’s integrated clinical solutions portfolio. With this partnership, our health plan clients can offer members a single entry point to the clinical and behavioral health support they need for obesity care and related illnesses,” said Ido Schoenberg, Amwell chairman and CEO. “Vida’s programs adapt to the patient’s needs, resulting in a personalized, cost-effective way to achieving weight loss requirements while applying an evidence-based, step therapy approach.”   

Amwell’s clinical programs portfolio features virtual and digital care products from partners addressing various health conditions. The portfolio is part of the company’s platform and provides health plans with the technology to offer employers and members a unified and delightful entry point to a comprehensive and dynamic set of orchestrated clinical programs. The result is a personalized and reportable whole-person care model focused on improving health outcomes and driving efficiencies.

About Vida Health

Vida Health is a virtual obesity and metabolic center of excellence that provides personalized care for individuals with obesity and related conditions. Vida’s holistic approach combines human care with AI-powered insights to deliver lasting health outcomes and help prevent and manage chronic diseases. Vida serves members in all 50 states, offering services in both English and Spanish, and operates on a value-based pricing model, putting outcomes at the center of care. To learn more, visit .

About Amwell

Amwell is a leading hybrid care delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. We offer a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the digital care of more than 50 health plans, which collectively represent more than 100 million covered lives, and many of the nation’s largest health systems. For more information, please visit .

©2025 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, Amwell ConvergeTM, CarepointTM and the Amwell logo are registered trademarks or trademarks of American Well Corporation.



Media:
Vida Health
Mim Harwood
 

Amwell
Angela Vogen
 

Investors:
Sue Dooley
 
(415) 602-9167
EN
15/01/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AMERICAN WELL CORP

 PRESS RELEASE

Amwell® makes grants to new employees under inducement plan

Amwell® makes grants to new employees under inducement plan BOSTON, Feb. 21, 2025 (GLOBE NEWSWIRE) --  (NYSE: AMWL), a leading technology-enabled care platform provider, announced that on Feb. 18, Amwell made grants of RSUs covering an aggregate of 16,737 shares of its Class A common stock to four new employees. The grants were offered as material inducement to the employees’ employment with Amwell. The RSUs will vest as follows, subject to the applicable employee’s continued employment through the applicable vesting date: 25% of the RSUs will vest upon the first anniversary of the grant ...

 PRESS RELEASE

Amwell® to participate in upcoming investor conference

Amwell® to participate in upcoming investor conference BOSTON, Feb. 19, 2025 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, will participate in an upcoming investor conference. Ido Schoenberg, M.D., Amwell chairman and chief executive officer, will participate in a fireside chat and one-on-one meetings at the TD Cowen 24th Annual Health Care conference in Boston on March 4. The fireside chat will be at 9:10 a.m. ET and an audio webcast of the fireside chat will be available at . About Amwell  Amwell offers paye...

 PRESS RELEASE

Amwell® Announces Results for Fourth Quarter and Full Year 2024

Amwell® Announces Results for Fourth Quarter and Full Year 2024 BOSTON, Feb. 12, 2025 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the fourth quarter and full year ended Dec. 31, 2024. Visit Amwell’s investor relations website at to view the fourth quarter and full year 2024 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, Feb. 12. The call can be accessed via a live audio webcast at . A replay of the call will...

 PRESS RELEASE

Amwell® to report fourth quarter and full year 2024 operating results

Amwell® to report fourth quarter and full year 2024 operating results BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leader in digital care, will report fourth quarter 2024 operating results after stock market trading hours on Wednesday, Feb. 12. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The full earnings report and the live audio webcast can be accessed by visiting the...

 PRESS RELEASE

Amwell® adds Vida to its clinical programs portfolio expanding access ...

Amwell® adds Vida to its clinical programs portfolio expanding access to obesity and diabetes care Vida to offer cardiometabolic solutions including GLP-1s and other anti-obesity medications on the Amwell platform BOSTON and SAN FRANCISCO, Jan. 15, 2025 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leader in digital care, today announced that , a leader in virtual cardiometabolic care, is now part of the clinical programs portfolio on the Amwell platform. The program, Amwell Cardiometabolic Care Powered by Vida, will be available to Amwell’s expansive client footprint of health plans and emplo...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch